Direct brain chemo tested against deadly breast cancer spread
NCT ID NCT06230055
Summary
This study is testing whether adding chemotherapy delivered directly into the spinal fluid (through a small implanted device called an Ommaya reservoir) works better than standard chemotherapy alone for people with HER2-negative breast cancer that has spread to the membranes surrounding the brain and spinal cord. Researchers want to see if this combined approach helps control the cancer in the nervous system longer and improves patients' quality of life. The trial is enrolling 37 adults whose cancer has progressed despite standard treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HER2-NEGATIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University
RECRUITINGShanghai, Shanghai Municipality, 200032, China
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.